References Stanley, T
In the context of IIH (idiopathic intracranial hypertension ), and RIH ( rebound intracranial hypertension ), the bodys inability to regulate the increase in CSF volume once a patient is sealed, GLP-1 medications are also starting to get attention
Proposed mechanisms include weight loss, systemic anti-inflammatory effects, and improved bioavailability of HS medications
Individual outcomes vary depending on the protocol, adherence, baseline health, diet, exercise, sleep, and other factors
Claim Strength Matrix for Skin, Hair, and Healing Claims Skin aging claims are moderate when limited to topical cosmetic outcomes, wound-healing claims are context-dependent because evidence includes both human diabetic-ulcer research and animal models, and hair growth claims remain preliminary or indirect [2], [3], [6], [13]
Research published in the British Journal of Dermatology demonstrated that MT-1 increased eumelanin content by 300400% in fair-skinned subjects with Fitzpatrick Type III skin after 10 days of dosing at 0.16mg/kg